Lavie Bio

Presence

Lavie Bio is owned by Compugen.

Compugen is a company listed under the stock ticker CGEN (IL).

Executives

View the org chart displaying its 10 main executives

Most searched biographies at Lavie Bio
Popular executive movements at Compugen
  • David Silberman will join the company as Chief Financial Officer on Aug. 15, 2024  (posted on May 16 2024).
  • Alberto Sessa, Chief Financial Officer, will leave the company on Aug. 15, 2024  (posted on May 16 2024).
  • Michelle Mahler who is Vice President of Clinical Development, will be promoted to Chief Medical Officer on Mar. 1, 2024  (posted on February 16 2024).

Click here to view some more movements at Compugen

Create your alert
to follow the executive moves at Lavie Bio.

Biotechnology

Compugen has 2,291 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by Lavie Bio
Social media about Lavie Bio

Get in Touch

Contact by email its executives including Amit Noam Premium

Call Lavie Bio at +972 ...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board